REQUEST A DEMO
Total
USD $0.00
Search more companies

Neurosciences Md Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Neurosciences Md Sas Profile Updated: October 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Neurosciences Md Sas is an enterprise in Colombia, with the main office in Medellin. It operates in the Ambulatory Health Care Services industry. It was established on October 07, 2020. Neurosciences Md Sas currently employs 4 (2024) people. From the latest financial highlights, Neurosciences Md Sas reported a net sales revenue increase of 177.84% in 2023. There was a total growth of 151.78% in Neurosciences Md Sas’s total assets over the same period. In, 2023, the company’s net profit margin increased by 63.92%.

Headquarters
Calle 53 45 64 Ed Tunapa Cs 209
Medellin; Antioquia;

Contact Details: Purchase the Neurosciences Md Sas report to view the information.

Basic Information
Total Employees:
Purchase the Neurosciences Md Sas report to view the information.
Outstanding Shares:
Purchase the Neurosciences Md Sas report to view the information.
Incorporation Date:
October 07, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Neurosciences Md Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
177.84%
Total operating revenue
177.84%
Operating profit (EBIT)
836.91%
Net Profit (Loss) for the Period
34110.1%
Total assets
151.78%
Total equity
140.51%
Operating Profit Margin (ROS)
45.33%
Net Profit Margin
63.92%
Return on Equity (ROE)
58.14%
Quick Ratio
-64.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?